|
Christophe L.M.J. Verlinde Associate Professor |
Survivor of renal cell carcinoma since 2000 and CIDP patient since 2002 |
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Recent results: Pharmacological characterization, structural studies, and in vivo activity of anti-Chagas disease lead compounds derived from Tipifarnib. Antimicrob. Agents Chemother. 56: 4914-4921 (2012) |
||
|
Recent results: Distinct states of methionyl tRNA-synthetase indicate binding of inhibitors by conformational selection. Structure 20: 1681-1691 (2012) |
||